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The permanent proliferation arrest, distended 
morphology and other phenotypic features characteristic 
of cellular senescence can be triggered by telomere 
attrition (replicative senescence) and various stresses 
such as activated oncogenes or genotoxic treatments 
(premature senescence). Physiological relevance of 
cellular senescence is apparent from its emerging roles 
in aging, in tumor pathogenesis as an inducible barrier 
to tumor progression, and in response to radiotherapy 
and chemotherapy [1]. Mechanistically, senescence 
induction and maintenance involve the major tumor 
suppressor pathways of pRB and p53, and persistent 
signaling of the DNA damage response (DDR) 
machinery [1]. An integral part of DNA damage 
signaling and senescence is the activation of a complex 
cytokine network [1,2] including proinflammatory 
species IL-6 and IL-8 and reorganization/multiplication 
of a specific nuclear compartment, PML nuclear bodies 
(PML NBs) [1,3]. Despite the critical roles of 
promyelocytic leukemia protein (PML), the structural 
component of PML NBs, in PML NBs assembly, tumor 
suppression, and stabilization and activation of p53 after 
various stresses, the molecular basis of PML regulation 
and its interplay with the senescence-associated 
secretory cytokine network are not well understood. A 
new study [4] now sheds light on the involvement of 
PML NBs in cellular senescence evoked by a spectrum 
of genotoxic drugs including clinically used 
chemotherapeutics, and provides important mechanistic 
insights into regulation of PML expression, causal 
relationship with cytokine signaling, and surprising lack 
of dependence on p53.  
 
Relevant findings preceding this study include the 
recent demonstration of cytokine signaling pathways 
involved in drug-evoked senescence [5],  and the fact 
that chemotherapy-induced senescence can occur in 
neighboring  cells  through so-called ‘bystander’  effects  
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[6]. The new work by Hubackova and colleagues [4] 
now shows that exposure of human normal and cancer 
cells to genotoxic drugs including those used to treat 
human malignancies such as camptothecin and 
etoposide, at concentrations evoking senescence and 
achievable in tissues during chemotherapy, resulted in 
enhanced formation of PML NBs, elevated PML 
transcript levels and activated JAK/STAT signaling 
indicative of cytokine involvement. As both endo-
genous PML transcript levels and PML promoter-driven 
luciferase activity were suppressed by chemical 
inhibition or RNAi-mediated knock-down of JAK1 
kinase, the data reveals a key role of JAK1-controlled 
signaling in PML transcription induced by genotoxic 
stress. Furthermore, in contrast to oncogene-induced 
senescence where PML expression is controlled by p53, 
the experiments of Hubackova et al. with both p53-
negative cells and regulatable dominant-negative allele of 
p53 showed that JAK1-regulated transcription of PML in 
response to genotoxic drugs is p53-independent [4].  
 
Considered within the context of other data in the field, 
these new results [4] help us better understand the 
interplay of PML with cytokine signaling in drug-
induced and ‘bystander’ senescence, phenomena highly 
relevant for aging, cancer biology and treatment 
response. 
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Figure 1. Model of PML and cytokine signaling in drug‐induced and ‘bystander’ senescence. Cytokine
secretion  and  autocrine/paracrine  signaling  triggered by  the  DDR  machinery  upregulate  PML  expression  and
formation of PML NBs, collectively leading to cellular senescence, both directly and through ‘bystander’ effects.  